Duration of benzodiazepine clinical activity: Lack of direct relationship with plasma half-life - A comparison of single vs divided dosage schedules of prazepam
ANSSEAU, Marc; Doumont, Adrienne; von Frenckell, Rémyet al.
Duration of benzodiazepine clinical activity: Lack of direct relationship with plasma half-life - A comparison of single vs divided dosage schedules of prazepam
Achte K. (1980) Use of benzodiazepines in psychiatric inpatients. Arzneimittelforsch 30:902-905.
Aein R., Leishman B. (1980) Importance of pharmacokinetic data for clinical practice. Benzodiazepines today and tomorrow , R.G., Priest, U.V., Filho, R., Aein, M., Skreta, MTP Press, Lancaster, England; 61-75.
Anhalt H.S., Young R., Roginsky M. (1980) Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs TID dosing. J Clin Psychiatry 41:386-392.
Ansseau M., Doumont A., Diricq (1984) Methodology required to show clinical differences between benzodiazepines. Curr Med Res Opin 8:108-114.
Barbizet J. (1979) Etude comparative prazepam — diazepam en milieu psychiatrioue. Psychologie Médicale (Paris) 11:1525-1532.
Balter M.B., Manheimer D.I., Mellinger G.D., Uhlenhuth E.H. (1984) A cross-national comparison of anti-anxiety/sedative drug use. Curr Med Res Opin 8:5-20.
Bellantuono C., Reggi V., Tognoni G., Garattini S. (1980) Benzodiazepines: Clinical pharmacology and therapeutic use. Drugs 19:195-219.
Bergamo M.L., Sudol T.E. (1982) Value of once daily dosing of diazepam questioned- and defended. J Clin Psychopharmacol 2:355-356.
Blackwell B. (1976) Treatment adherence. Br J Psychiatry 129:513-531.
Bond A., Lader M. (1974) The use of analogue scales in rating subjective feelings. British Journal of Medical Psychology 47:211-218.
Bowden C.L. (1978) Double-blind placebo-controlled trial of ketazolam in anxiety. Curr Ther Res 24:170-178.
Breimer D.D., Jocheen R., von Albert H.H. (1980) Pharmacokinetics of benzodiazepines: Short-acting versus long-acting. Arzneimittelforsch 30:875-881.
Burrows D.G., Dumovic P., Smith J.A., Norman T., Maguire K. (1977) A controlled comparative trial of clorazepate (Tranxene) and diazepam (Valium) for anxiety. Med J Aust 2:525-528.
(1980) Systematic review of the benzodiazepines: Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Br Med J , Committee on the Review of Medicines; 280:910-912.
Detti I. (1983) Benzodiazepines in the treatment of insomnia: Pharmacokinetic considerations. The benzodiazepines: From molecular biology to clinical practice , E., Costa, Raven Press, New York; 173-199.
Dunlop E., Weisberg J. (1968) Double-blind study of prazepam in the treatment of anxiety. Psychosomatics 9:75-78.
Dureman I., Malmgren H., Norrman B. (1978) Comparison studies of clorazepate administered as a divided daily dose and as a single dose at night. Psychopharmacology 57:123-126.
Fabre L.F., McLendon D.M. (1979) Ketazolam administered once-a-day compared to clorazepate TID and placebo in a double-blind study to anxious outpatients. Curr Ther Res 25:710-720.
Fabre L.F., Harris R.T., Stubbs D.F. (1976) Double-blind placebo-controlled efficacy study of ketazolam (U-28,774). J Int Med Res 4:50-54.
Fabre L.F., McLendon D.M., Gainey A. (1978) Double-blind comparison of ketazolam administered once-a-day with diazepam and placebo in anxious outpatients. Curr Ther Res 24:875-882.
Fabre L.F., McLendon D.M., Mallette A. (1980) Phase IV out-patient comparison study of prazepam against placebo, diazepam, and chlorazepate dipotassium in anxiety. Curr Ther Res 28:784-791.
Feighner J.P. (1980) Ketazolam once-a-day in the treatment of anxiety: A double-blind comparison with diazepam and placebo. Curr Ther Res 28:425-431.
Fontaine R., Annable L., Chouinard G., Ogilvie R.I. (1983) Bromazepam and diazepam in generalized anxiety: A placebo-controlled study with measurement of drug plasma concentrations. J Clin Psychopharmacol 3:80-87.
Gallant D.M., Guerrero-Figueroa R., Swanson W.C. (1973) U-28,774 (ketazolam): An early evaluation of new antianxiety agent. Curr Ther Res 15:123-126.
Goldberg H.L., Finnerty R.J. (1977) A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety. Compr Psychiatry 18:147-155.
Greenblatt D.J., Shader R.I. (1978) Pharmacotherapy of anxiety with benzodiazepines and β-adrenergic blockers. Psychopharmacology: A generation of progress , M.A., Lipton, A., DiMascio, K.F., Killam, Raven Press, New York; 1381-1390.
Greenblatt D.J., Shader R.I. (1978) Prazepam and lorazepam, two new benzodiazepines. N Engl J Med 299:1342-1344.
Greenblatt D.J., Shader R.I., Abernethy D.R. (1983) Current status of benzodiazepines. N Engl J Med 309:410-416.
Guy W. ECDEU Assessment Manual for Psychopharmacology, 3rd ed., National Institute of Mental Health, Rockville; 1976.
.
.
Hamilton M. (1959) The assessment of anxiety states by ratings. Br J Med Psychol 32:50-55.
Kaplan S.A., Jack M.L. (1983) Metabolism of the benzodiazepines: Pharmacokinetic and pharmacodynamic considerations. The Benzodiazepines: From molecular biology to clinical practice , E., Costa, Raven Press, New York; 173-199.
Kaplan S.A., Jack M.L., Alexander K., Weinfeld R.E. (1973) Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J Pharm Sci 62:1789-1796.
Kim K.K., Sirman A., Trainor F.S., Lee B.Y. (1980) Anxiolytic efficacy and safety of ketazolam compared with diazepam and placebo. Clin Ther Res 8:159-163.
Kingstone E., Villeneuve A., Kossatz I. (1966) Prazepam in the treatment of anxiety and tension: A clinical study of a new benzodiazepine derivative. Cur Ther Res 8:159-163.
Kingstone E., Villeneuve A., Kossafz I. (1969) Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotics with anxiety and tension: Some methodological considerations. Curr Ther Res 11:106-114.
Kleber R.J. (1980) Ketazolam compared to diazepam and placebo in the treatment of anxiety. J Int Med Res 8:439-445.
Kurowski M., Ott H., Herrmann W.M. (1982) Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam. Pharmacopsychiatria 15:77-83.
Lader M. (1983) Benzodiazepine withdrawal states. Benzodiazepines divided , Trimble, John Wiley and Sons, Chichester; 17-32.
Magnus R.V. (1973) Once-a-day potassium clorazepate in anxiety. Br J Clin Pract 27:449-452.
Magnus R.V., Dean B.C., Curry S.H. (1977) Clorazepate: Double-blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety. Dis Nerv Syst 38:819-821.
Mellinger G.D., Balter M.B., Uhlenhuth E.H. (1984) Prevalence and correlates of the long term regular use of anxiolytics. JAMA 251:375-379.
Miller R.D., Strickland R., Davidson J., Parrot R. (1983) Characteristics of schizophrenics and depressed patients excluded from clinical research. Am J Psychiatry 140:1205-1207.
Möhler H., Richards J.G. (1983) Benzodiazepines receptors in the central nervous system. The benzodiazepines: From molecular biology to clinical practice , E., Costa, Raven Press, New York; 93-116.
Owieczka J., Van Meerbeeck, Nystrom C., Lens F. (1981) Double-blind comparison of ketazolam and placebo administered once-a-day in the treatment of anxiety. Acta Ther 7:159-174.
Petursson H., Lader R.H. (1981) Withdrawal from long-term benzodiazepine treatment. Br Med J 283:643-645.
Post C., Lindgren S., Bertler A., Malmgren H. (1977) Pharmaco-kinetics of N-desmethyldiazepam in healthy volunteers after single daily doses of dipotassium clorazepate. Psychopharmacology 53:105-109.
Rickels K. (1980) Benzodiazepines 1980: Current update (discussion). Psychosomatics [Suppl] 21:26.
Rickels K., Sablosky L., Silverman H., Case W.G., Rial W., Mirman M., Gottlieb S. (1977) Prazepam in anxiety: A controlled clinical trial. Comp Psychiatry 18:239-249.
Rickels K., Case W.G., Csanalosi I., Weise C.C., Goldstein M.E., Greisman P. (1980) Ketazolam, diazepam and placebo in anxious outpatients: A controlled study. J Clin Pharmacol 20:581.
Rickels K., Case G., Downing R.W., Winokur A. (1983) Long-term diazepam therapy and clinical outcome. JAMA 250:767-771.
Shader R.I., Greenblatt D.J. (1980) Benzodiazepines: Some aspects of their clinical pharmacology. Ciba Foundation Symposium 74: Drug concentrations in neuropsychiatry , Excerpta Medica, Amsterdam; 141-155.
Shaffer J.W., Yeganeh M.L., Foxwell N.H., Kurland A.A. (1968) A comparison of the effects of prazepam, chlordiazepoxide and placebo in the short-term treatment of convalescing alcoholics. J Clin Pharmacol 6:392-399.
Smith M.T., Evans L.E.J., Eadie M.J., Tyrer J.H. (1979) Pharmaco-kinetics of prazepam in man. Eur J Clin Pharmacol 16:773-782.
Solomon K., Hart R. (1978) Pitfalls and prospects in clinical research on antianxiety drugs: Benzodiazepines and placebo —A research review. J Clin Psychiatry 39:823-831.
Spitzer R., Endicott J., Robins E. (1978) Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 34:773-782.
Sugerman A.A., Miksztal M.W., Freymuth H.W. (1971) Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts. J Clin Pharmacol 11:383-387.
Tyrer P., Rutherford D., Huggett T. (1981) Benzodiazepine withdrawal symptoms and propanolol. Lancet 1:520-522.
Tyrer P., Owen R., Dawling S. (1983) Gradual withdrawal of diazepam after long-term therapy. Lancet 1:1402-1406.
Warnecke G. (1977) Demetrin versus Placebo: Über die Wirkung von Prazepam bei psychosomatischen und vegetativ funktionellen Beschwerdebildern in der gynäkologischen Sprechstunde. Therapiewoche 27:8407-8417.
Weir J.H. (1978) Prazepam in the treatment of anxiety: A placebo-controlled multicenter evaluation. J Clin Psychiatry 39:841-847.